Parkinson’s Disease Research
Enrolling Now

Adults with Parkinson’s disease who experience low blood pressure symptoms
when standing may be eligible for a clinical study.

Participation includes 1 screening visit, an in-clinic stay of up to 5 days, and 1 follow-up phone call.

Compensation up to $1,700 may be available for time and travel.

Dr. Aaron Ellenbogen and the Quest Research Team continue to enroll in promising new Parkinson's trials.

Dr. Aaron Ellenbogen is a board-certified neurologist and Movement Disorders Specialist with more than 22 years of clinical research experience and nearly 100 completed clinical trials. He is a published physician, active member of the International Parkinson and Movement Disorder Society (MDS), and has contributed to more than 72 research publications. 
His research experience spans a broad range of therapeutic areas including Parkinson’s disease, Alzheimer’s disease, multiple sclerosis (MS), pain management, and diabetic peripheral neuropathic pain (DPNP). Throughout his career, Dr. Ellenbogen has remained committed to advancing medicine and expanding treatment options for diverse patient populations.